Ligand validation:6NMF

CHD: CHOLIC ACID

CHD is a Ligand Of Interest in 6NMF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NMF_CHD_P_307	91%	48%	0.087	0.974	0.71	1.28	-	5	1	0	100%	1
6NMF_CHD_B_303	89%	43%	0.098	0.977	0.71	1.48	1	7	0	0	100%	1
6NMF_CHD_C_306	88%	45%	0.101	0.976	0.9	1.2	-	7	0	0	100%	1
6NMF_CHD_G_104	79%	39%	0.119	0.965	0.82	1.53	-	10	0	0	100%	1
6NMF_CHD_P_306	36%	41%	0.23	0.924	0.56	1.69	-	15	0	0	100%	1
6NMF_CHD_C_305	25%	44%	0.247	0.885	0.62	1.54	-	8	0	0	100%	1
6NMF_CHD_J_101	12%	38%	0.32	0.846	0.82	1.6	-	5	2	0	100%	1
6NMF_CHD_W_101	3%	27%	0.413	0.765	0.81	2.1	1	15	1	0	100%	1
7TIE_CHD_G_107	98%	64%	0.052	0.977	0.64	0.75	-	-	0	0	100%	1
3AG2_CHD_B_304	97%	32%	0.063	0.981	1.03	1.63	3	12	0	0	100%	1
6NMP_CHD_C_303	96%	58%	0.075	0.982	0.56	1.02	-	2	1	0	100%	1
7VUW_CHD_B_305	96%	32%	0.064	0.97	1.01	1.67	-	13	0	0	100%	1
7YPY_CHD_B_303	95%	35%	0.057	0.962	1.09	1.48	2	10	0	0	100%	1
5B1B_CHD_G_103	95%	40%	0.058	0.962	0.87	1.45	1	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.